This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
De La Rue PLC (DLAR.L) – Saw full-year operating profit fall 11% from £62.8m in the year ended March 31, from £70.7m y-o-y, which was in line with its lowered guidance, after it spent £4m on a failed bid to print post-Brexit passports and made less profit on its paper business. Closing price 508.00p (Reuters)
Fresnillo PLC (FRES.L) – At its AGM reported over $2.23bn in adjusted revenue in 2017, which showed a rise of 9.2% against the previous year, with a 32.0% increase in profit for the period. Closing price 1335.00p (Dow Jones Newswire)
AstraZeneca PLC (AZN.L) – Failed to meet the primary endpoint of a statistically-significant reduction of exacerbations in patients with chronic obstructive pulmonary disease, the second of two pivotal phase three drug trials for ‘Terranova’ showed, after previously this month ‘Galathea’ also failed phase three trials. Closing price 5412.00p (Dow Jones Newswire)
Scottish Southern Energy (SSE.L) – The UK competition regulator has issued further details regarding examination content of its investigation of the tie-up between the retail power units of SSE and Innogy's Npower. Closing price 1374.50p (Reuters)
Royal Bank of Scotland (RBS.L) – Announces CFO and Executive Director Ewen Stevenson has resigned to take up an opportunity elsewhere. This comes, pending an announcement from the lender on the government sale of its shares this week. Closing price 280.48p (Sigma Squawk)
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ROYAL BANK OF SCOTLAND | RBS | -3.3% | -0.6% | -4.4% |
| STANDARD LIFE ABERDEEN | SLA | -2.5% | -0.3% | -3.0% |
| ITV | ITV | -3.2% | -0.7% | -3.4% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research